Prognostic implications of vitamin D deficiency in chronic kidney disease
Article Sidebar
Main Article Content
Abstract
Chronic kidney disease (CKD) is a highly prevalent disease, imposing high mortality rates worldwide, and it is closely related to cardiovascular events. Vitamin D deficiency is very prevalent in patients with CKD from the earliest stages of the disease, and it has been associated with higher mortality. In order to assess the prognostic implications of vitamin D deficiency in CKD, we undertook a literature review, searching different databases in October 2018 for publications related to vitamin D in patients with CKD and hypovitaminosis D, and not on dialysis. The main cause of death in these patients is cardiovascular disease. Vitamin D is one of the first parameters that CKD changes and has an important prognostic role in this entity. Deficient levels in blood are associated with increased cardiovascular risk and survival impacts, independently of cardiovascular disease. Treatment with paricalcitol appears to reduce this risk. However, the evidence analyzed is insufficient to establish an association between vitamin D levels and the progression of kidney disease.
Article Details
Copyright (c) 2019 Martínez-López D, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017; 389(10075): 1238-1252. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27887750
Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010; 30: 78-86. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20038967
Holick M. Vitamin D Deficiency. New England Journal of Medicine. 2007; 357: 266-281. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17634462
Liu W, Wu C, Hung Y, Liao M, Shyu J, Lin Y et al. Pleiotropic effects of vitamin D in chronic kidney disease. Clinica Chimica Acta. 2016; 453: 1-12. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26656443
Obi Y, Hamano T, Isaka Y. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers. 2015; 2015: 868961. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25883412
Bess Dawson-Hughes. 2018 Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment. UpToDate [Internet]. 2019. http:///www-uptodate.com
Holick M. High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proc. 2006; 81: 353-373. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16529140
Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson-Hughes B, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International. 2009; 20: 1807-1820. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19543765
Jordi B, Jesús E, Elvira FG. Vitamina D, receptor de la vitamina D e importancia de su activación en el paciente con enfermedad renal crónica. Nefrología. 2015: 35: 1-12.
Dusso A, González E, Martin K. Vitamin D in chronic kidney disease. Best Practice & Research Clinical Endocrinology & Metabolism. 2011; 25: 647-655. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21872805
Yuste C, García De Vinuesa S, Goicoechea M. Deficiencia de vitamina D en una cohorte española de pacientes con enfermedad renal crónica. Medicina Clínica. 2013; 141: 338-342.
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-38. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17091124
Qunibi WY, Henrich WL. Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD). [online] Uptodate.com 2019. http:///www-uptodate.com
Currie G, Delles C. Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis. 2013; 7: 13-24. PubMed:
Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW, et al . Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. BMJ Open. 2017; 7: e016528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28838895
Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017; 100: 41-49. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28115282
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296–1305. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15385656
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659–663. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15037495
Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012; 307: 674-684. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22337679
García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011; 26: 2250-2256. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20956810
Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis. 2012; 220: 265-268. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22071357
Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1128-1135. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19443628
Mehrotra R. Hypovitaminosis D and Progression of CKD. Chronic Kidney Disease in Disadvantaged Populations. 2017: 251-262.
Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009; 76: 977-983. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19657329
Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75: 88-95. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18843258
Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011; 58: 374-382. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21636193
Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011; 58: 536-543. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21816525
Mariani LH, White MT, Shults J, Anderson CA, Feldman HI, et al. Increasing Use of Vitamin D Supplementation in the Chronic Renal Insufficiency Cohort Study. J Ren Nutr. 2014; 24: 186–193. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24613295
Duranton F, Rodriguez-Ortiz M, Duny Y, Rodriguez M, Daurès J, et al. Vitamin D Treatment and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Am J Nephrol. 2013; 37: 239-248. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23467111
Mann MC, Hobbs AJ, Hemmelgarn BR, Roberts DJ, Ahmed SB, et al. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J. 2014; 8: 41-48. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25713709
Hu X, Shang J, Yuan W, Zhang S, Jiang Y, et al. Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease: A meta-analysis. Herz. 2018; 43: 518-528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28835982